AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
OneMedNet shares surge 13.61% after-hours on Palantir partnership boosting AI and healthcare data growth.
ByAinvest
Tuesday, Dec 2, 2025 4:13 pm ET1min read
OneMedNet surged 13.61% in after-hours trading following multiple developments enhancing its healthcare data capabilities. The stock’s rise coincided with news of a new partnership with Palantir, expanding its AI and healthcare data footprint, alongside the addition of 85 cardiovascular centers and 2.7 million annual cardiovascular studies to its network. These developments, announced on August 20, 2025, underscored OneMedNet’s growth in real-world data offerings and strategic collaborations, fueling bullish sentiment ahead of earnings. Earlier in the month, a partnership with Inka Health for AI-driven oncology projects and a subscription revenue model with Circle CVI further reinforced its commercial expansion. Combined with a 80% debt reduction reported on August 14 and a 25% network expansion in July, these factors positioned the company for improved growth prospects in AI-powered healthcare analytics.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet